Filter
896
Filtered Results: 896
Text search:
Ministry
of
Health,
Guinea
Featured
Recommendations
85
New Publications
321
Language
Document type
No document type
572
Studies & Reports
191
Guidelines
58
Manuals
26
Strategic & Response Plan
25
Training Material
8
Situation Updates
6
Fact sheets
5
Infographics
3
Resource Platforms
2
Countries / Regions
Sierra Leone
118
Liberia
101
Guinea
69
Global
43
Senegal
34
Congo, Democratic Republic of
29
Africa
29
Nigeria
27
Ethiopia
22
Ghana
22
Uganda
21
Kenya
20
Rwanda
16
Cameroon
15
Burkina Faso
12
Mali
12
Côte d’Ivoire / Ivory Coast
12
Asia
12
West and Central Africa
9
India
8
Mozambique
8
Niger
7
Chad
7
Indonesia
7
Togo
6
Myanmar / Burma
6
Guinea-Bissau
5
Afghanistan
5
Tanzania
5
South Africa
5
Benin
5
Central African Republic
5
South–East Asia Region
5
Western Pacific Region
5
Zimbabwe
4
Somalia
4
Nepal
4
South Sudan
4
Bangladesh
4
Namibia
4
East and Southern Africa
4
Western and Central Europe
4
Philippines
3
Pakistan
3
Zambia
3
Cambodia
3
Gambia
3
Papua New Guinea
3
Colombia
3
Lesotho
3
Latin America and the Carribbean
3
Haiti
2
Syria
2
Thailand
2
Malawi
2
Peru
2
Eswatini/ Swaziland
2
Brazil
2
Botswana
2
Angola
2
Madagascar
2
Yemen
2
Eastern Europe
2
Saudi Arabia
1
Iraq
1
Jordan
1
Germany
1
Mauritania
1
Sudan
1
Vanuatu
1
Argentina
1
Ecuador
1
Bolivia
1
Greece
1
Libya
1
Sri Lanka
1
Chile
1
Middle East and North Africa
1
Solomon Islands
1
Venezuela
1
North Korea
1
Italy
1
Timor Leste/ East Timor
1
Russia
1
Lithuania
1
Iran
1
North America
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
268
Clinical Guidelines
69
Public Health
55
Women & Child Health
45
Key Resources
37
Capacity Building
11
Pharmacy & Technologies
7
Toolboxes
Ebola
169
HIV
67
COVID-19
51
Rapid Response
49
Disability
35
Planetary Health
35
Mental Health
31
NTDs
29
TB
28
Global Health Education
19
Caregiver
16
Refugee
12
AMR
12
Pharmacy
11
Health Financing Toolbox
11
Conflict
9
Polio
8
Natural Hazards
8
Cholera
5
NCDs
5
Specific Hazards
4
Zika
2
Health Financing
1
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact inves...
COVID-19 has heavily emphasized how contact tracing is crucial for managing outbreaks, and as part of the strategy for adjusting, and eventually lifting, lockdowns and other stringent public health ...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was published in 2016 with the objective of i...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution ... staff in WHO Regional and Country Offices has been invaluable: in gather-ing original data and information from Member States, in supporting the process of aggregation of these data; and in reviewing the regional analysis of the findings that reflect the country situation at the point when the survey was conducted. The support and commitment of the members of the WHO Task Force on Antimicrobial Resistance, comprising WHO staff from Headquarters and Regional Offices has, is also acknowledged.
During the first year of the Covid-19 pandemic, the world’s economy slowed. Yet, the global annual average particulate pollution (PM2.5) was largely unchanged from 2019 levels. At the same time, growing evidence shows air pollution—even when exp...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim ... the document is to assist Member States and relevant partners in their discussions to identify the best approaches to ensure the accelerated evaluation and use of available or near-term therapies and vaccines for the treatment and prevention of EVD. The document calls for a coordinated effort by the international community to remove unnecessary obstacles towards this goal.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in develop...
This Framework offers a coherent approach for eliminating tuberculosis (TB) in low-incidence countries. It is designed to guide national policy-makers and those responsible for technical aspects of the national TB response in accelerating efforts to...
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-preventable diseases. This responsibility has been t...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part ... monitoring this progress, countries have adopted the Every Newborn Tracking Tool. This report presents a compilation of the data collated by the Every Newborn Tracking Tool in 2016, when 51 countries adopted the tool; it also spotlights examples of specific country activity for each National Milestone. Finally, Global Milestones for 2020 were part of the Every Newborn Action Plan to guide global and regional work in support of country efforts and this report highlights relevant progress towards those Global Milestones.
Managing epidemics
recommended
Key facts about major deadly diseases.This manual provides concise and up-to-date knowledge on 15 infectious diseases that have the potential to become international threats, and tips on how to respond to each of them.
You can download an interacti...
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals endorsed by the World Health Assembly. The plan sets out the: vision, goals and targets for the 2011-...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up in...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions ... access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patient...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but ...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections...
